Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Omega Healthcare InvestorsBSP:O2HI34 46 3-Year Revenue Growth Rate is 2.80% as of Jun. 2026, which is 20% below its 10-year median of 3.50. GuruFocus rates BSP:O2HI34 with a GF Score™ of 46/100 and a GF Value™ of R$70.35 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 792 REITs companies, Omega Healthcare Investors ranks worse than 50.38% on this metric.
During the past 12 months, Omega Healthcare Investors's average Revenue per Share Growth Rate was 6.50% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 2.80% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -0.40% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -1.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Omega Healthcare Investors was 61.20% per year. The lowest was -45.60% per year. And the median was 3.50% per year.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.
Omega Healthcare Investors 3-Year Revenue Growth Rate Related Terms
BSP:O2HI34 vs DOC, AHR, CTRE: 3-Year Revenue Growth Rate Comparison
For the REIT - Healthcare Facilities subindustry, Omega Healthcare Investors's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Omega Healthcare Investors 3-Year Revenue Growth Rate vs REITs Industry
For the REITs industry and Real Estate sector, Omega Healthcare Investors's 3-Year Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where Omega Healthcare Investors's 3-Year Revenue Growth Rate falls into.
This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
What does a 3-Year Revenue Growth Rate of 2.80% mean?
Omega Healthcare Investors (BSP:O2HI34) has a 3-Year Revenue Growth Rate of 2.80% as of Jun. 2026. 3-Year Revenue Growth Rate is the 3-year average growth rate of Revenue per share. View historical data for Omega Healthcare Investors and its competitors. This is 20% below median its historical median of 3.50. According to the industry distribution chart, Omega Healthcare Investors ranks #399 out of 792 companies in the REITs industry, placing it in the top 50.4%.
Is Omega Healthcare Investors' 3-Year Revenue Growth Rate too high?
Omega Healthcare Investors' current 3-Year Revenue Growth Rate of 2.80% is 20% below median its 10-year median of 3.50. The REITs industry median 3-Year Revenue Growth Rate is 2.90. Omega Healthcare Investors' value of 2.80% is 3.4% below this industry median. Based on the distribution chart, Omega Healthcare Investors ranks #399 out of 792 companies in the REITs industry, which is below the industry midpoint. Overall, Omega Healthcare Investors has a GF Score™ of 46/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Omega Healthcare Investors' 3-Year Revenue Growth Rate compare to DOC and AHR?
According to the REITs industry distribution chart, Omega Healthcare Investors ranks #399 out of 792 companies for 3-Year Revenue Growth Rate. This places Omega Healthcare Investors in the lower half of its industry. The industry median 3-Year Revenue Growth Rate is 2.90. Omega Healthcare Investors' value of 2.80% is 3.4% below this benchmark. While the company's 10-year median is 3.50 vs. the industry median of 2.90, Omega Healthcare Investors has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Revenue Growth Rate for a REITs company?
The median 3-Year Revenue Growth Rate among REITs companies is 2.90, based on 792 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Revenue Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Revenue Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Omega Healthcare Investors's current 3-Year Revenue Growth Rate of 2.80% is 3.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Revenue Growth Rate mean?
A high 3-Year Revenue Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Revenue Growth Rate is the 3-year average growth rate of Revenue per share. View historical data for Omega Healthcare Investors and its competitors. For the REITs industry, the median 3-Year Revenue Growth Rate is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Omega Healthcare Investors's current 3-Year Revenue Growth Rate is 2.80%, which is 20% below median its own 10-year median of 3.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omega Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, Omega Healthcare Investors (BSP:O2HI34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$70.35, compared to a current price of R$81.84 — trading 16.3% above its estimated fair value. The current 3-Year Revenue Growth Rate is 2.80%, which is 20% below median its 10-year median of 3.50 and 3.4% below the REITs industry median of 2.90. Omega Healthcare Investors' overall GF Score™ is 46/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Revenue Growth Rate calculated?
3-Year Revenue Growth Rate is calculated from a company's financial statements. For Omega Healthcare Investors (BSP:O2HI34), the current 3-Year Revenue Growth Rate is 2.80% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Omega Healthcare Investors (BSP:O2HI34) Overvalued in 2026?
Based on GuruFocus' analysis, Omega Healthcare Investors stock appears to be overvalued.
The current stock price of R$81.84 is trading 16.3% above its estimated GF Value™ of R$70.35.
GuruFocus considers Omega Healthcare Investors to be Modestly Overvalued.
Key valuation signals for BSP:O2HI34:
3-Year Revenue Growth Rate: 2.80% (20% below median its 10-year median of 3.50)
GF Value™: R$70.35 vs. price of R$81.84 (16.3% above fair value)
Industry Position: 3.4% below the REITs median (#399 of 792)
No single metric tells the full story. See the BSP:O2HI34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
46GF Score
Get the complete analysis for BSP:O2HI34
3-Year Revenue Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:O2HI34 has been successfully added to your 
